Search

Author/Creator Hildebrandt, B.

21. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS). (May 2023)

Authors:
Kuendgen, A.; Nomdedeu, M.; Tuechler, H.; Garcia-Manero, G.; Komrokji, R.; Sekeres, M.; Della Porta, M.; Cazzola, M.; Dezern, A.; Roboz, G.; Steensma, D.; Van De Loosdrecht, A.; Malcovati, L.; Schlenk, R.; Grau, J.; Calvo, X.; Blum, S.; Pereira, A.; Valent, P.; Costa, D.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF PROGNOSTICATION BY IPSS-M, IPSS-R AND AIPSS-MDS IN THE CONTEXT OF LIMITED AVAILABILITY OF MOLECULAR DATA IN DAILY CLINICAL PRACTICE. (May 2023)

Authors:
Schulz, F.; Kellersmann, C.; Betz, B.; Hildebrandt, B.; Thol, F.; Heuser, M.; Ganster, C.; Beier, F.; Sockel, K.; Hofmann, W.-K.; Kuendgen, A.; Pfeilstoecker, M.; Gattermann, N.; Nachtkamp, K.; Haase, D.; Germing, U.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: INTERMEDIATE RISK KARYOTYPE BY IPSS-R CAN BE SEPARATED INTO 5 PROGNOSTICALLY DISTINCT SUBGROUPS IN MDS PATIENTS. (May 2023)

Authors:
Nachtkamp, K.; Flatten, V.; Hildebrandt, B.; Kasprzak, A.; Schulz, F.; Strupp, C.; Haase, D.; Ganster, C.; Shirneshan, K.; Rittscher, K.; Götze, K.; Hofmann, W.-K.; Platzbecker, U.; Pfeilstöcker, M.; Valent, P.; Blum, S.; Lübbert, M.; Parmentier, S.; Beier, F.; Sockel, K.
Journal:
Leukemia research
Issue:
Volume 128(2023)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗